One other thing that doesn't make a lot of sense to me in the article if Mesoblast was involved is the bit about the costs of running trials in China, in columns 4 and 5. Not an issue in relation to Mesoblast, Tasly bears the costs.
Mesoblast - takeover target?, page-32
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.020(1.68%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.17 | $2.778M | 2.330M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 33037 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 19401 | 9 |
View Market Depth
| Last trade - 12.03pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |